Currently, therapeutic targets in CRSwNP focus on various interleukins such as IL-4, IL-5, and IL-13 produced by Th2 lymphocytes or immunoglobulins such as IgE, produced by B lymphocytes or plasma cells [117,118,119]. Here, IL4 is linked to chronic rhinosinusitis with nasal polyps.